|
Report on the DNA analysis from skeletal remains from
two skulls
conduced by Trace Genetics
August 12, 2003

Two sets of remains were received by Trace Genetics and
were processed for genetic
analyses. The remains consisted of two skulls presented
by Mr. Lloyd Pye for DNA analysis.
SAMPLING
Prior to attempts to extract DNA from the remains, the
remains were inventoried and
taped using a video camera. Video records of the
sampling procedure and the initial extraction
on all samples were taken and archived by Trace
Genetics.
Samples were cut from the left parietal of an abnormally
shaped skull, identified as the
Starchild skull on February 10, 2003. Equipment used to
sample was sterilized using a bleach
solution prior to use. Sampling was performed in a room
not used for any genetic analyses.
Fragments weighing a total of 0.8g were cut from the
parietal using a rotary cutter with a
previously unused blade. The fragments were placed in a
sterile conical tube labeled SCS-1 and
stored for analysis. A second 0.7g fragment adjacent to
the sample retained by Trace Genetics
was placed in a sterile conical tube labeled SCS-2 and
returned to Mr. Pye.
Two teeth were removed from maxilla of a skull presented
in association with the
Starchild skull on February 10, 2003. The right first
molar tooth and root weighing 1.7g was
removed and labeled “SA-1.” The tooth and root were
placed in a sterile conical tube and
retained for genetic analysis by Trace Genetics. A
portion of the root was fractured in the
process and remained in the maxilla. The right premolar
and root (sample labeled “SA-2”; total
weight 1.0g) were also removed from the maxilla, placed
in a sterile conical tube. The SA-2
sample was returned to Mr. Pye.
EXTRACTION AND ANALYSIS OF DNA
SCS-1:
Extraction 1:
A first extraction was performed on a 0.24g fragment of
the parietal bone from sample
SCS-1. The extraction was performed in a dedicated
ancient DNA laboratory beginning on 7
March 2003 and was performed in parallel to an
extraction of SA-1 and a reagent blank (negative
control). Both surfaces of bone were sanded with a
rotary sander to remove any surface
contaminants and lacquer preserves present on the outer
surfaces of bone. Subsequent to
sanding, the bone was exposed to ultraviolet (UV)
irradiation (254nm) for 300 seconds per side.
The bone surface was then cleaned with bleach (2% sodium
hypochlorite), rinsed with sterile
EDTA and placed in a fresh 15ml conical tube and
immersed in approximately 2ml of 0.5M
EDTA. The tube was sealed with parafilm and placed on a
rocker.
After 10 days, the tube was opened and 150μl of 0.1M PTB
[1] and 20μl of 100mg/ml
proteinase-K was added to the sample and EDTA. The
sample was incubated with agitation
overnight at 64 oC.
DNA was extracted from the digested sample using a 3-step
phenol/chloroform extraction method. Two extractions
with phenol:chloroform:isoamyl
(25:24:1) of equal volume to the digested product were
followed by an extraction with an equal
volume of chloroform:isoamyl (24:1). The extracted DNA
solution was concentrated by
ammonium-acetate precipitation using two volumes of cold
100% filtered ethanol and 1/2
volume of 5M ammonium acetate. This solution was then
stored at -20 °C
for approximately 4
hours to facilitate precipitation, then centrifuged at
high speeds (10,000-12,000rpm) for 15
minutes to pellet the precipitated DNA. The supernatant
was discarded and the remaining DNA
pellet dried and resuspended in ~300μl sterile ddH 2O.
To further purify the DNA and remove
additional PCR inhibitors co-extracted with the DNA, the
DNA solution was purified using the
Promega â
Wizard PCR Preps DNA Purification Kit as
directed by the manufacturer. DNA was
eluted from Promega â
columns with 100μl sterile ddH2O,
the elutant labeled SCSex1 and stored
at –20 °C.
Attempts to amplify segments of mtDNA from extract
SCSex1 were performed as
described below in METHODS. Single amplifications for
fragments containing the diagnostic
mutations for Native American haplogroups A, B, C and
D[2] did not reveal a known Native
American haplogroup, however, the extraction did not
amplify consistently. A single
amplification of a fragment of the mtDNA first
hypervariable segment (HVSI) between np
16210 and np 16328 was sequenced using a cycle
sequencing procedure with ABI Big-Dye 3.1
chemistry and analyzed on an ABI automated genetic
analyzer. The sequence obtained revealed
a transition relative to the Cambridge reference
sequence at np16273. This sequence did not
match either any personnel with access to the ancient
DNA facilities or a sequence obtained from
Mr. Pye. Subsequent amplifications of this fragment were
not successful and the sequence could
not be confirmed. Attempts to amplify fragments of the
amelogenin gene located on the X and Y
chromosome[3] were uniformly not successful.
Extraction 2:
A second extraction was performed beginning April 21,
2003 on 0.21g of the parietal
sample from SCS-1. The extraction was performed as above
with the following modifications:
1. The sample was run in
parallel with a reagent blank (negative control) but was not
processed with any other
samples.
2. The bone was exposed to 900
seconds of UV irradiation per side.
3. The bone was completely
immersed in 2% sodium hypochlorite for 5 minutes.
4. The sample was left in EDTA
with agitation for 22 days prior to digestion with
proteinase-K.
5. At digestion, ~50μl of
Tween-20 was added with 100μl of PTB.
6. The silica extraction
columns (Promega®) were eluted with 80μl of ddH 2O
and
sample labeled “SCSe2.”
Attempts to amplify mtDNA for fragments containing the
diagnostic mutations for
Native American haplogroups A, B, C and D were performed
on extract SCSe2. Multiple
amplifications indicated that the sample possessed an
AluI restriction site at np 13262 indicative
of Native American haplogroup C [2]. Sequence obtained
for a fragment of the first
hypervariable segment of the mtDNA control region from
np16210 to np 16367 revealed
transitions at np16223, np 16298, np 16325 and np 16327.
These mutations are characteristic of
haplogroup C in the Americas [4].
Multiple attempts to amplify a segment of the amelogenin
gene were unsuccessful using
various amounts of SCSe2 extract as template. 30μl of
the original extract was concentrated to a
final volume of ~10μl using a microcon YM-30
concentrator. Attempts to amplify this
concentrated template were not successful.
Extraction 3:
A third extraction was performed beginning on June 4,
2003 as described above for
extraction 2 with the following modifications:
1. The extraction was
performed on the entire remaining 0.40g of bone.
2. The sample was immersed in
~3.5ml of EDTA.
3. To ensure adequate
demineralization of the sample, the sample was left immersed in
EDTA with agitation for 30
days.
4. The final elution from the
silica spin columns (Promega®) was performed twice, each
time with 35μl of ddH 2O
preheated to 65oC.
Attempts to amplify fragments of mtDNA were performed to
test for the presence of
diagnostic mutations fo r Native American haplogroups A
and C. The sample did not appear to
possess the diagnostic HaeIII mutation and np663
indicative of haplogroup A. Multiple
amplifications did reveal the presence of the AluI site
gain at np13262 indicative of haplogroup C.
A single amplification of a fragment of the amelogenin
gene located on the X and Y
chromosomes [3] produced a single amplification product
106bp in length. Multiple subsequent
amplifications did not reproduce this event, as all
subsequent attempts did not produce a PCR
product.
SA-1:
Extraction 1:
A first extraction was performed on 0.53g fragment of
the molar tooth from sample SA-1
beginning on 7 March 2003 and was performed in parallel
to an extraction of SCS-1 (above) and
a reagent blank (negative control). The extraction was
performed in the manner describe above
for extraction 1 of SCS-1 save that the outer surface of
the tooth, which had previous to sampling
been firmly rooted in the maxilla, was not sanded and
the final elution of the silica spin column
(Promega®) was eluted to 100μl and labeled SAex1.
Multiple attempts to amplify segments of mtDNA
containing amplifications for
fragments of mtDNA containing the diagnostic mutations
for Native American haplogroup A
revealed a HaeIII restriction site at np663
consistent with known Native American haplogroup A
[2]. Amplifications for fragments containing the
diagnostic sites for haplogroups B, C and D did
not show presence of mutations indicative of these
haplogroups. A single amplification of a
fragment of the mtDNA first hypervariable segment (HVSI)
between np 16210 and np 16327
revealed transitions relative to the Cambridge reference
sequence at np16223, np16290 and
np16319. These mutations are consistent with Native
American haplogroup A.
Multiple amplifications of a fragment of the amelogenin
gene on the X and Y
chromosomes consistently produced a single band 106bp in
length when visualized on an
electrophoretic gel consistent with DNA from a female
[3].
Extraction 2:
A second extraction was performed beginning Ap ril 21,
2003 on 0.42g of the tooth
sample from SA-1. The extraction was performed similar
to extraction 1 on SA-1 (above) with
the following modifications:
1. The sample was not run in parallel to any samples
from SCS-1.
2. The sample was immersed in EDTA for 26 days prior to
digestion with proteinase-K.
The final elution was labeled SAe2 and stored at –20 oC.
Multiple amplifications of a mtDNA fragment indicated
the presence of a HaeIII
restriction site at np663 indicative of Native American
haplogroup A. Amplifications of the
extraction did not possess the AluI site gain at
np16262. Multiple amplifications of a fragment of
the amelogenin gene produced a single band when
visualized on an electrophoretic gel consistent
with DNA from a female.
DISCUSSION:
MtDNA from virtually all modern, full-blooded Native
Americans belongs to one of five
mitochondrial lineages or matrilines (designated
haplogroups A, B, C, D, and X) marked by the
presence or absence of characteristic restriction sites
or by the presence of a nine base pair (9-bp)
deletion [2, 5]. Analyses of ancient DNA from Native
Americans likewise indicates that these
haplogroups constitute virtually all prehistoric Native
American individuals as well [see: 6].
The sample taken from the Starchild Skull (SCS-1) has
mtDNA consistent with Native
American haplogroup C, as revealed through two
independent extractions performed on
fragments of parietal bone. While a single first
extraction did not appear to type similarly, this
inconsistent result is likely a product of a low level
of contamination. This single extraction
neither amplified consistently nor was the single
sequence of HVSI reproducible. Contamination
could have occurred either prior to sampling, introduced
in the extraction process, or during PCR
amplifications. It is unlikely that contamination could
account for the haplogroup C mtDNA as
this type is not possessed by any researcher with access
to the ancient DNA facilities and the
reagent blanks did not indicate systematic contamination
in the extractions.
The sample taken from the associated skull (SA-1) has
mtDNA consistent with Native
American haplogroup A as determined through both
extractions. The sample also appeared be
from a female individual as evidenced by repeated
amelogenin typing. It is unlikely that
contamination could account for the haplogroup A mtDNA
as this type is not possessed by any
researcher with access to the ancient DNA facilities and
the reagent blanks did not indicate
systematic contamination in the extractions.
As mtDNA exists in high copy number (upwards of three
orders of magnitude relative to
any single copy nuclear DNA locus), it can be recovered
from prehistoric biological material in
sufficient quantities for amplification and analysis
using the polymerase chain reaction (PCR)
[see: 7, 8]. MtDNA is present in haploid condition with
inheritance being passed down
exclusively through maternal lines [9]. Thus, that the
samples analyzed from SCS-1 and SA-1
possessed markedly different mtDNA types excludes a
mother-offspring relationship between
the two individuals. As it was possible to type and
confirm both to known pre-Columbian
mtDNA types found in the Americas, both individuals most
appear to have possessed Native
American mothers.
While it is possible to obtain nuclear DNA as well from
ancient samples, the reduced
copy-number at any particular nuclear locus relative to
mtDNA makes it less likely that a
particular extract will contain sufficient DNA for the
analysis of a nuclear genetic locus using
presently available PCR methods. The ability to amplify
nuclear DNA from the SA-1
extractions but not from the SCS-1 extractions could be
a product of any of a number of factors.
In ancient DNA analysis, success rates from teeth are
generally higher than from bone [10, 11].
Further, there is some indication that X-Ray exposure
damages and degrades DNA, which may
have decreased the quantity and quality of DNA available
in the bone prior to extraction. The
lone amplification using the amelogenin primers on
extract SCSe3 could not be confirmed
through additional amplifications and likely indicates a
sporadic contamination of a single PCR
reaction caused either by a female individual in the
laboratory or could have been introduced to
laboratory disposables (e.g. pipette tips, PCR reaction
tubes). Such contamination has been
noted elsewhere [12] and consequently, any conclusions
drawn from the single un-reproduced
PCR reaction should not be taken as any reliable
indication as to the DNA present in the sample.
The presence of reliably typed mtDNA from SCS samples
does indicate that mtDNA is
present in the bone. The inability to analyze nuclear
DNA indicates that such DNA is either not
present or present in sufficiently low copy number to
prevent PCR analysis using methods
available at the present time.
AMPLIFICATION METHODS
All reagents used to extract and amplify were first
tested to detect any DNA
contamination and ancient DNA facilities were cleaned
using bleach to remove possible sources
of contamination. Further additional contamination
controls and precautions are described
below.
PCR amplifications of mtDNA were conducted in 25 μl
volumes using 4μl dNTPs
( 10mM),
2.5μl 10X PCR buffer (Gibco), 1.3μl BSA (20mg/ml), 0.75μl MgCl2,
0.2μl Platinum
Taq DNA polymerase (Gibco) 2 to 6 μl of DNA template and
sterile ddH20 sufficient to bring
reaction volume to 25μl. After an initial 4- minute
denaturation step at 94 o
C to activate the hot
start Taq, 40 PCR cycles were performed consisting of a
94 oC
denaturing step, a 50-55oC
annealing step (temperature depending on primers
utilized), and a 72 oC
extension step of 30
seconds each. A final 3- minute extension at 72 oC
was added after the last cycle. A portion of
the amplification product (~5μl) was run on a 6%
polyacrylamide gel together with a size
standard ladder, stained with ethidium bromide and
photographed under UV light using a digital
imager (ISO 2000 imaging system, Alpha Innotech, San
Leandro, CA). To assess the presence
or absence of diagnostic restriction sites, the
remaining 20μl were incubated with 10 units of the
appropriate restriction enzyme overnight at 37 o
C, and then subjected to
electrophoresis in the
manner previously described. Primers used for
amplification of these segments and restriction
enzymes used are shown in table 1.
Amelogenin amplifications [3] were attempted using 1, 3,
and 8 μl of DNA template in
25 μl reaction volumes, adjusting ddH 2O
amounts to maintain concentrations of other reagents.

CONTAMINATION CONTROLS:
Ancient DNA is typically highly degraded and survives in
much lower copy numbers
than modern DNA. Consequently, ancient DNA is highly
vulnerable to contamination from
modern sources and specific precautions against
contamination, as summarized by Kelman and
Kelman [18], were utilized in this study to both
minimize contamination and, importantly, to
identify contamination when present so that it does not
lead to false inferences. These measures
include: 1. Use of dedicated laboratory space, supplies,
reagents and equipment for preparation
of ancient DNA samples inside UV irradiated glove boxes;
2. Use of sterile, disposable labware
and clothing whenever possible; 3. Use of separate pre-
and post-PCR facilities; 4. Periodic UV
irradiation and bleaching of all materials used to help
eliminate any surface contamination; 5.
Running negative controls at all stages of the
extraction and amplification process to identify the
presence of contaminants; 6. Confirmation of results by
multiple amplifications of multiple
extractions. All positive results were confirmed though
multiple amplifications of each
extraction and multiple extractions performed at
different times.
References Cited
1. Poinar, H.N., et al., Molecular coproscopy: Dung
and diet of the extinct ground sloth
Nothrotheriops shastensis. Science (Washington D C),
1998. 281(5375): p. 402-406.
2. Schurr, T.G., et al., Amerindian mitochondrial
DNAs have rare Asian mutations at high
frequencies, suggesting they derived from four primary
maternal lineages. American
Journal of Human Genetics, 1990. 46(3): p.
613-23.
3. Mannucci, A., et al., Forensic Application of a
Rapid and Quantitative DNA Sex Test by
Amplification of the X-Y Homologous Gene Amelogenin.
International Journal of Legal
Medicine, 1994. 106(4): p. 190-193.
4. Torroni, A., et al., Asian affinities and
continental radiation of the four founding Native
American mtDNAs. American Journal of Human Genetics,
1993. 53(3): p. 563-590.
5. Forster, P., et al., Origin and evolution of
native American mDNA variation: A
reappraisal. American Journal of Human Genetics,
1996. 59(4): p. 935-945.
6. Eshleman, J.A., R.S. Malhi, and D.G. Smith,
Mitochondrial DNA Studies of Native
Americans: Conceptions and Misconceptions of the
Population Prehistory of the
Americas. Evolutionary Anthropology, 2003. 12(1):
p. 7-18.
7. Kaestle, F.A. and D.G. Smith, Ancient
mitochondrial DNA evidence for prehistoric
population movement: The Numic expansion. American
Journal of Physical
Anthropology, 2001. 115(1): p. 1-12.
8. Stone, A.C. and M. Stoneking, mtDNA analysis of a
prehistoric Oneota population:
Implications for the peopling of the New World.
American Journal of Human Genetics,
1998. 62: p. 1153-1170.
9. Giles, R.E., et al., Maternal Inheritance of human
mitochondrial DNA. Proceedings of
the National Academy of Sciences of the United States of
America, 1980. 77(11): p.
6715-6719.
10. Malhi, R.S., Investigating prehistoric population
movements in North America with
ancient and modern mtDNA, in Anthropology.
2001, University of California: Davis.
11. Hummel, S., Ancient DNA Typing: methods,
strategies and applications. 2003, Berlin:
Springer-Verlag.
12. Schmidt, T., S. Hummel, and B. Herrmann, Evidence
of contamination in PCR
laboratory disposables. Naturwissenschaften, 1995.
82(9): p. 423-431.
13. Stone, A.C. and M. Stoneking, Ancient DNA from a
pre-Columbian Amerindian
population. American Journal of Physical
Anthropology, 1993. 92(4): p. 463-471.
14. Wrischnik, L.A., et al., Length mutations in
human mitochondrial DNA: direct
sequencing of enzymatically amplified DNA. Nucleic
Acids Research, 1987. 15: p. 529-
542.
15. Handt, O., et al., The retrieval of ancient human
DNA sequences. American Journal of
Human Genetics, 1996. 59(2): p. 368-376.
16. Parr, R.L., S.W. Carlyle, and D.H. O'Rourke,
Ancient DNA analysis of Fremont
Amerindians of the Great Salt Lake Wetlands.
American Journal of Physical
Anthropology, 1996. 99(4): p. 507-518.
17. Eshleman, J.A., Mitochondrial DNA and prehistoric
population movements in Western
North America, in Anthropology. 2002,
University of California, Davis: Davis, CA.
18. Kelman, L.M. and Z. Kelman, The use of ancient
DNA in paleontological studies. Journal
of Vertebrate Paleontology, 1999. 19(1): p. 8-20.
|